Sartorius Stedim Biotech annual operating margin
2020
2021
2022
2023
2024
2025
Sartorius Stedim Biotech's operating margin was 17.72% for fiscal 2025.
View full Sartorius Stedim Biotech company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 17.72% | +4.38 pp |
| 2024 | 2024-12-31 | 13.33% | −2.86 pp |
| 2023 | 2023-12-31 | 16.20% | −12.30 pp |
| 2022 | 2022-12-31 | 28.49% | −1.48 pp |
| 2021 | 2021-12-31 | 29.98% | +5.28 pp |
| 2020 | 2020-12-31 | 24.70% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 20.11% | +2.80 pp |
| Q1 2026 | 2026-03-31 | 19.61% | +0.63 pp |
| Q4 2025 | 2025-12-31 | 17.40% | — |
| Q2 2025 | 2025-06-30 | 17.32% | — |
| Q1 2025 | 2025-03-31 | 18.98% | — |
Over the last five fiscal years, Sartorius Stedim Biotech's operating margin decreased from 24.70% to 17.72%, a change of −6.98 percentage points. The latest reported quarter, Q2 2026, shows 20.11%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as reported operating income divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sartorius Stedim Biotech source filings ↗